Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma.

Kuzuya T, Katano Y, Kumada T, Toyoda H, Nakano I, Hirooka Y, Itoh A, Ishigami M, Hayashi K, Honda T, Goto H.

J Gastroenterol Hepatol. 2007 Nov;22(11):1929-35.

PMID:
17914972
2.

Prevention of hepatocellular carcinoma in hepatitis B virus infection.

Lim SG, Mohammed R, Yuen MF, Kao JH.

J Gastroenterol Hepatol. 2009 Aug;24(8):1352-7. doi: 10.1111/j.1440-1746.2009.05985.x. Review.

PMID:
19702903
3.

Nucleot(s)ide analogues for hepatitis B virus-related hepatocellular carcinoma after curative treatment: a systematic review and meta-analysis.

Sun P, Dong X, Cheng X, Hu Q, Zheng Q.

PLoS One. 2014 Jul 24;9(7):e102761. doi: 10.1371/journal.pone.0102761. eCollection 2014. Review.

4.

Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma.

Wei Q, Xu X, Ling Q, Zhou B, Zheng SS.

Hepatobiliary Pancreat Dis Int. 2013 Jun;12(3):251-5. Review.

5.
6.

Impact of antiviral therapy on post-hepatectomy outcome for hepatitis B-related hepatocellular carcinoma.

Chong CC, Wong GL, Lai PB.

World J Gastroenterol. 2014 May 28;20(20):6006-12. doi: 10.3748/wjg.v20.i20.6006. Review.

7.

Anti-viral therapy to reduce recurrence and improve survival in hepatitis B virus-related hepatocellular carcinoma.

Ishikawa T.

World J Gastroenterol. 2013 Dec 21;19(47):8861-6. doi: 10.3748/wjg.v19.i47.8861. Review.

8.

Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma.

Zhong JH, Li le Q, Wu LC.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD008713. doi: 10.1002/14651858.CD008713.pub2. Review.

PMID:
22161435
9.

Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.

Kubo S, Takemura S, Tanaka S, Shinkawa H, Nishioka T, Nozawa A, Kinoshita M, Hamano G, Ito T, Urata Y.

World J Gastroenterol. 2015 Jul 21;21(27):8249-55. doi: 10.3748/wjg.v21.i27.8249. Review.

10.

Antiviral therapies for hepatitis B virus-related hepatocellular carcinoma.

Zhang YQ, Guo JS.

World J Gastroenterol. 2015 Apr 7;21(13):3860-6. doi: 10.3748/wjg.v21.i13.3860. Review.

11.

Role of antiviral therapy in the management of hepatocellular carcinoma.

Guan YS, He Q.

Anticancer Drugs. 2013 Apr;24(4):337-43. doi: 10.1097/CAD.0b013e32835ec39a. Review.

PMID:
23388161
12.

Antiviral therapy decreases recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection: a meta-analysis.

Zhou Y, Zhang Z, Zhao Y, Wu L, Li B.

World J Surg. 2014 Sep;38(9):2395-402. doi: 10.1007/s00268-014-2586-z. Review.

PMID:
24791945
13.

Hepatitis B viral load affects prognosis of hepatocellular carcinoma.

Yu SJ, Kim YJ.

World J Gastroenterol. 2014 Sep 14;20(34):12039-44. doi: 10.3748/wjg.v20.i34.12039. Review.

14.

Does anti-HBV therapy benefit the prognosis of HBV-related hepatocellular carcinoma following hepatectomy?

Yu LH, Li N, Shi J, Guo WX, Wu MC, Cheng SQ.

Ann Surg Oncol. 2014 Mar;21(3):1010-5. Review.

PMID:
24121884
15.

Resection of hepatitis B virus-related hepatocellular carcinoma: evolving strategies and emerging therapies to improve outcome.

Chau GY.

World J Gastroenterol. 2014 Sep 21;20(35):12473-84. doi: 10.3748/wjg.v20.i35.12473. Review.

16.

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.

Papatheodoridis GV, Lampertico P, Manolakopoulos S, Lok A.

J Hepatol. 2010 Aug;53(2):348-56. doi: 10.1016/j.jhep.2010.02.035. Epub 2010 Apr 27. Review.

17.

Does antiviral therapy for chronic hepatitis B reduce the risk of hepatocellular carcinoma?

Abu-Amara M, Feld JJ.

Semin Liver Dis. 2013 May;33(2):157-66. doi: 10.1055/s-0033-1345719. Epub 2013 Jun 8. Review.

PMID:
23749672
18.

Prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.

Kim BK, Han KH, Ahn SH.

Oncology. 2011;81 Suppl 1:41-9. doi: 10.1159/000333258. Epub 2011 Dec 22. Review.

PMID:
22212935
19.

Effects of antiviral therapy on preventing liver tumorigenesis and hepatocellular carcinoma recurrence.

Tan ZM, Sun BC.

World J Gastroenterol. 2013 Dec 21;19(47):8895-901. doi: 10.3748/wjg.v19.i47.8895. Review.

20.

Effect of adjuvant interferon therapy on hepatitis b/c virus-related hepatocellular carcinoma after curative therapy - meta-analysis.

Xu J, Li J, Chen J, Liu ZJ.

Adv Clin Exp Med. 2015 Mar-Apr;24(2):331-40. doi: 10.17219/acem/29760. Review.

Items per page

Supplemental Content

Write to the Help Desk